https://www.vectorytx.com/events daily 0.75 2025-09-15 https://www.vectorytx.com/events/lipids-in-brain-diseases-symposium-2025 monthly 0.5 2025-09-09 https://www.vectorytx.com/events/american-society-of-gene-and-cell-therapy-asgct-annual-meeting monthly 0.5 2025-05-06 https://www.vectorytx.com/events/09pzo6mpq3x3d42mxycslqi4utofln monthly 0.5 2025-05-06 https://www.vectorytx.com/news daily 0.75 2026-02-09 https://www.vectorytx.com/news/vectory-therapeutics-announces-first-participant-dosed-in-phase-1/2-pioneer-als-clinical-trial-of-vtx-002-in-people-with-amyotrophic-lateral-sclerosis-als monthly 0.5 2026-02-09 https://www.vectorytx.com/news/vectory-therapeutics-appoints-kevin-pojasek-phd-to-board-of-directors monthly 0.5 2026-02-05 https://www.vectorytx.com/news/vectory-therapeutics-receives-fda-clearance-of-ind-to-proceed-with-the-pioneer-als-phase-1/2-trial-of-vtx-002-a-first-in-class-vectorized-antibody-targeting-tdp-43-pathology-in-als-p8bg8 monthly 0.5 2026-01-08 https://www.vectorytx.com/news/vectory-therapeutics-receives-fda-clearance-of-ind-to-proceed-with-the-pioneer-als-phase-1/2-trial-of-vtx-002-a-first-in-class-vectorized-antibody-targeting-tdp-43-pathology-in-als monthly 0.5 2026-01-07 https://www.vectorytx.com/news/vectory-at-esgct-showcasing-innovation-in-vectorized-antibody-therapies-for-cns-disorders monthly 0.5 2025-10-02 https://www.vectorytx.com/news/vectory-therapeutics-and-shape-therapeutics-announce-option-and-license-agreement-to-advance-vectorized-antibodies-for-neurodegenerative-diseases-using-an-aav5-derived-cns-capsid monthly 0.5 2025-09-18 https://www.vectorytx.com/news/vectory-therapeutics-appoints-jessica-atkinson-as-chief-business-officer monthly 0.5 2025-05-27 https://www.vectorytx.com/news/vectory-therapeutics-to-present-preclinical-data-on-novel-als-therapeutic-strategy-at-target-als-conference-in-boston monthly 0.5 2025-05-07 https://www.vectorytx.com/news/vectory-therapeutics-announces-multiple-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-annual-meeting-2025 monthly 0.5 2025-04-29 https://www.vectorytx.com/news/vectory-therapeutics-appoints-olga-uspenskaya-cadoz-aschief-medical-officer monthly 0.5 2025-04-01 https://www.vectorytx.com/news/vectory-strengthens-leadership-team-with-appointment-of-jim-scibetta-as-new-ceo monthly 0.5 2024-12-16 https://www.vectorytx.com/news/vectory-appoints-seasoned-biotech-leader-adam-rosenberg-as-chair-of-the-board monthly 0.5 2024-07-09 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/3b0aef00-6d62-4b1c-909c-f23bd1e3ca66/Adam+Rosenberg.png News - VectorY Appoints Seasoned Biotech Leader Adam Rosenberg as Chair of the Board - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/umc-utrecht-and-vectory-therapeutics-collaborate-in-als-biomarker-study monthly 0.5 2024-06-17 https://www.vectorytx.com/news/span-classsqsrte-text-color-darkaccentvectory-to-participate-in-key-sector-events-in-june-2024span monthly 0.5 2024-06-14 https://www.vectorytx.com/news/9otjaf3e47jiimca1oo80nenfbfaq6 monthly 0.5 2024-01-18 https://www.vectorytx.com/news/vectory-raises-129-million-138-million-series-a-financing-to-advance-vectorized-antibody-programs-in-neurodegenerative-diseases monthly 0.5 2023-11-13 https://www.vectorytx.com/news/vectory-to-present-at-the-asgct-annual-meeting-in-may-2023 monthly 0.5 2023-05-01 https://www.vectorytx.com/news/vectory-to-present-at-the-bioquity-europe-conference-in-may monthly 0.5 2023-04-14 https://www.vectorytx.com/news/vectory-to-participate-in-key-sector-conferences-in-april-2023 monthly 0.5 2023-04-05 https://www.vectorytx.com/news/vectory-appoints-michael-wyzga-as-cfo-and-adds-jean-franchi-to-its-board-of-directors monthly 0.5 2023-03-20 https://www.vectorytx.com/news/vectory-and-annogen-announce-research-collaboration-for-the-development-of-cns-cell-specific-promoters monthly 0.5 2023-03-07 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/53f692d9-f3c4-412f-b64f-3f5ba1c2fc4e/Annogen+VectorY+-+website+2.jpg News - VectorY and Annogen Announce Research Collaboration for the Development of CNS-cell Specific Promoters - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/launching-vectorys-new-corporate-identity monthly 0.5 2023-01-17 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/6e449a05-9996-4a4c-93b1-431e1ad01003/New+Year+New+Brand.png News - Launching VectorY’s new corporate identity - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/vectory-appoints-sander-van-deventer-as-ceo-and-makes-key-appointments-to-its-leadership-team monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/6caff8c7-67f7-4392-a475-1486a9d54e19/SandervanDeventer_1.jpg News - VectorY Appoints Sander van Deventer as CEO and makes Key Appointments to its Leadership Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/vectory-to-participate-in-the-jefferies-and-jp-morgan-healthcare-conferences monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/1670580610104-QTDAA2OZOVR1VLO7FIMM/Jefferies+JP+Morgan_xx.PNG News - VectorY to Participate in the Jefferies and JP Morgan Healthcare Conferences - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/vectory-announces-participation-in-scientific-conferences-in-october-2022 monthly 0.5 2023-01-10 https://www.vectorytx.com/news/vectory-to-present-poster-on-huntingtons-preclinical-data-at-the-hereditary-disease-foundation monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/1670580610098-GCKOC23C19AN6HU88UH1/svetlana_rob_29-08-2022.jpg News - VectorY to Present Poster on Huntington’s Preclinical Data at the Hereditary Disease Foundation, August 24-27 in Cambridge, MA - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/vectory-is-participating-in-a-large-cureq-consortium-named-predict-delay-cure-polyglutamineq-caused-neurodegeneration monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/1670580610072-BX559ULQF5SJNOT7YNXZ/Vectory+huntington.jpg News - VectorY is participating in a large cureQ consortium named “Predict, Delay & Cure polyglutamine(Q) caused neurodegeneration”. - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/vectory-and-wageningen-university-sign-strategic-collaboration-for-the-development-of-novel-baculovirus-based-aav-production-technologies monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/1670580637446-ND8AM9S6NBZ6M13DDF4E/vectoryimage.jpeg News - VectorY and Wageningen University sign strategic collaboration for the development of novel baculovirus-based AAV production technologies - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/assembling-a-new-gene-therapy-company-to-develop-the-next-generation-of-pioneering-medicines monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/1670580610063-ACHHNHN5H6YVBCBU3I5Q/foto+charlotte_Christina.jpg News - Assembling a new gene therapy company to develop the next generation of pioneering medicines https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/1670580610057-VRC2FG46J33X9DMR6OKC/christina.jpg News - Assembling a new gene therapy company to develop the next generation of pioneering medicines - Christina Maat Junior Technician at VectorY Christina is a Junior Technician at VectorY working in the vector development team. After having worked as a research assistant on human post mortem brain pathology (at the Amsterdam UMC), she continued studying the brain in a more mechanistic way during her Master’s in Biology at ETH Zürich in Switzerland. At VectorY, Christina supports the vector development team in advancing the application of biological mechanisms, for developing effective gene therapies. Her active lifestyle and curious nature match the diverse places in which she has lived. While she reminisces hiking the Swiss Alps or exploring California’s coastline, forests and mountains ranges, biking through the city of Amsterdam on a sunny day feels equally great! https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/1670580610060-4QDBYFF2H55ECRTT99GZ/charlotte.jpg News - Assembling a new gene therapy company to develop the next generation of pioneering medicines - Charlotte McLure Junior Technician at VectorY Charlotte is a Junior Technician at VectorY working in the process development team. Her background is in Chemistry and she holds a Master’s in Chemistry with Environmental and Sustainable Chemistry from The University of Edinburgh. The life-sciences world is therefore new to Charlotte, but she has thoroughly enjoyed building up her understanding of gene therapy and of bioprocessing. Originally from Scotland, she loves to ski and to mountain bike. Upon arrival in the flattest country in Europe, she swapped her mountain bike for a race bike and enjoys exploring The Netherlands at great speed in this way. In her free time she likes to dance at festivals and to talk about her cat. https://www.vectorytx.com/news/vectory-raises-31-million-in-seed-financing-to-develop-next-generation-gene-therapies-aimed-at-muscular-and-cns-disorders monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/4a15534f-48a8-423d-9208-f38609897100/HV+2020+October+16+73.jpg News - VectorY raises €31 million in seed financing to develop next-generation gene therapies aimed at muscular and CNS disorders - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/vectory-strengthens-leadership-with-appointments-of-new-ceo-and-cto monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/0eeda941-6afc-4ad5-9fa8-defdd29ec86e/HV+2020+October+16+314.jpg News - VectorY strengthens leadership with appointments of new CEO and CTO - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/vectory-presents-at-asgct-2021-about-advances-and-challenges-of-vectorized-antibodies-for-the-treatment-of-neuromuscular-diseases monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/1670580610043-KCNF82L8VE8LMTYU7FV4/image001.png News - VectorY presents at ASGCT 2021 about advances and challenges of vectorized antibodies for the treatment of neuromuscular diseases. - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/vectory-have-been-selected-as-winners-of-the-merck-millipore-2021-european-advance-biotech-program monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/1670580610030-02VVR322E41PELA6S7BL/Finalist-VectorY_Congratulations_MRK_1200x650.png News - VectorY have been selected as winners of the Merck Millipore 2021 European Advance Biotech Program! - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/news/launch-of-novel-gene-therapy-company-vectory-to-develop-innovative-vectorized-antibodies monthly 0.5 2023-01-10 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/e2a8d96e-94f7-4087-9750-15bd3c000f56/HV+2020+October+16+86.jpg News - Launch of novel gene therapy company, VectorY, to develop innovative vectorized antibodies - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/about-us daily 0.75 2025-09-18 https://www.vectorytx.com/contact daily 0.75 2024-06-03 https://www.vectorytx.com/vectorized-antibody-platform daily 0.75 2025-09-24 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/bd171a8b-fce7-462a-929d-1e7a0f292254/Screenshot+2025-09-24+at+16.17.32.png Vectorized Antibody Platform https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/22f4b876-66eb-414a-a6e9-0b14cb88d5e0/Screenshot+2025-09-24+at+18.57.54.png Vectorized Antibody Platform https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/d07c0fec-2023-4a71-a809-c481fd236767/Screenshot+2025-09-24+at+19.00.04.png Vectorized Antibody Platform https://www.vectorytx.com/home daily 1.0 2026-04-02 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/31085991-26b0-462b-b1e9-84dad237d794/Vectory_LAB_Hennis2025_1.jpg home - Our programs We have a strong pipeline of potentially disease-modifying vectorized antibody treatments for neurodegenerative diseases including ALS, Huntington’s, and Parkinson’s disease. https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/1679064380420-VPGSXFBV1O8E6BMLMSRB/HV+2020+October+16+73.jpg home - The platform Based on extensive internal knowhow, a unique platform has been developed that combines state-of-the-art intracellular antibodies, AAV capsids, and manufacturing. https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/f391d388-3b63-477d-b087-3d28426a02e2/HV+2020+October+16+7.jpg home - What’s new ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VectorY Therapeutics Appoints Kevin Pojasek, Ph.D., to Board of Directors https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/8e030717-8715-4c66-9b54-d21520eb9a81/HV+2020+October+16+202.jpg home - Work at VectorY We are growing fast and therefore we are always looking for enthusiastic and dedicated professionals to join our team. Learn more about working at VectorY and search job openings. https://www.vectorytx.com/careers daily 0.75 2026-03-19 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/9253e7ae-124b-4dc0-9893-913bf3fad45e/Vectory_LAB_Hennis2025_26.jpg Careers - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/00bfdcba-f8cf-4092-bc38-9c668fae9e97/Vectory_Office_Hennis2025_14.jpg Careers - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/leadershipold daily 0.75 2025-07-22 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/3aa1c122-61a0-4fc6-b781-1c2c54821f45/20241212_Photo+Jim.jpeg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/dee35645-0c8e-476b-963d-f7fbef21a6a6/SandervanDeventer_1.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/dae7eca6-5789-4c7c-b3cd-55fdda4d6719/Jessica+Atkinson+-+VectorY.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/c4285495-eea5-4cfa-94fb-9ea03e9a62a2/Olga+Headshot+Photo_3_25_25.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/8a1c7f3c-8631-49c3-ad2b-3a972f2ee7a1/Barbera2.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/e5fafa83-427d-458b-b286-4b5db5ea08dc/44_Rodin+Therapeutics_Genevieve+de+Manio+Photography.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/281acb8b-5c43-4526-84c3-08698668c098/Marco+Boorsma.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/58813f04-3097-41e8-8055-744286e07d35/Jean+Franchi.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/ba17df02-eb16-47af-9cfe-05fd4a905260/20231208_Wouter_Forbion.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/e0a0d6b6-8f80-403d-ac00-df39a1954b21/20231208_Photo+Karin_Merck.PNG https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/e52e029e-3710-4ab2-acde-e1ed18514142/20231208_Photo+Arno+EQT.PNG https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/89143ccd-6432-4df0-bf52-d73d63a207e7/20241212_Photo+Jim.jpeg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/c38a9542-dd1c-42b8-8836-53f091ec7637/Merit+Cudkowicz.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/27537e45-448f-4e06-b16e-a171d297543f/Philip+van+Damme.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/9365a2ba-256b-4a73-8ad6-c9237fda9774/Philippe+Corcia.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/e7c8c81b-c33c-4a29-8190-f515335a9039/Eric+Reits.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/92d58e20-4cb0-4b8c-ba8c-1f529802ece1/Ralf+Reilmann.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/d345c851-4468-4c44-91c8-b8d262c02824/Ton+Logtenberg.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/c7c7ba9f-0954-4cd6-9b2e-697ac44065f8/Emanuele+Buratti.jpg https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/f9d1f89d-ccb0-4e47-97d3-bd28f14dc12e/Pietro+Fratta.jpg https://www.vectorytx.com/scientific-publications daily 0.75 2026-03-18 https://www.vectorytx.com/pipeline daily 0.75 2026-02-09 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/4dfb68a4-1835-4b50-b1c6-046fa52c1613/pipeline-v4.png https://www.vectorytx.com/vtx002-for-als daily 0.75 2025-05-08 https://www.vectorytx.com/vtx-003-for-huntingtons daily 0.75 2023-03-17 https://www.vectorytx.com/interns daily 0.75 2024-06-03 https://www.vectorytx.com/scientist-computational-biology daily 0.75 2024-06-03 https://www.vectorytx.com/scientist-vector-technologies daily 0.75 2024-06-03 https://www.vectorytx.com/sr-scientist-assay-development daily 0.75 2024-06-03 https://www.vectorytx.com/technician-gene-therapy daily 0.75 2024-11-19 https://www.vectorytx.com/scientist-process-development-usp daily 0.75 2024-06-03 https://www.vectorytx.com/technician-assay-development daily 0.75 2024-06-03 https://www.vectorytx.com/scientist-downstream-process-development-dsp daily 0.75 2024-06-03 https://www.vectorytx.com/sr-technician-process-development-usp daily 0.75 2024-06-03 https://www.vectorytx.com/head-of-assay-development daily 0.75 2024-06-03 https://www.vectorytx.com/programmanager daily 0.75 2024-06-03 https://www.vectorytx.com/scientist-vectorized-antibody-therapy daily 0.75 2024-09-05 https://www.vectorytx.com/head-of-facility-and-lab-operations daily 0.75 2024-06-03 https://www.vectorytx.com/scientisttranslational-biology daily 0.75 2024-06-03 https://www.vectorytx.com/juniorfinancialanalyst daily 0.75 2024-06-03 https://www.vectorytx.com/scientist-vector-technology daily 0.75 2024-06-03 https://www.vectorytx.com/scientist-upstream-process-development daily 0.75 2024-06-03 https://www.vectorytx.com/bioanalytical-laboratory-technician daily 0.75 2024-06-03 https://www.vectorytx.com/technology-transfer-specialist daily 0.75 2023-10-06 https://www.vectorytx.com/press-releases-2 daily 0.75 2023-11-13 https://www.vectorytx.com/scientist-translational-biomarkers daily 0.75 2023-12-08 https://www.vectorytx.com/qa-manager daily 0.75 2023-12-12 https://www.vectorytx.com/hr-director daily 0.75 2024-08-08 https://www.vectorytx.com/qa-officer daily 0.75 2024-01-11 https://www.vectorytx.com/scientist-assay-development daily 0.75 2024-05-31 https://www.vectorytx.com/scientist-pre-clinical-translational daily 0.75 2024-06-03 https://www.vectorytx.com/project-manager daily 0.75 2025-07-31 https://www.vectorytx.com/senior-scientist daily 0.75 2024-03-19 https://www.vectorytx.com/press-releases-key-sector-events daily 0.75 2024-06-17 https://www.vectorytx.com/press-release-umcutrecht-vectory daily 0.75 2024-06-16 https://www.vectorytx.com/scientist-vd daily 0.75 2024-06-25 https://www.vectorytx.com/press-release-adam-rosenberg daily 0.75 2024-07-09 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/63a4af24-9969-43f4-975a-35e5db92f761/Adam+Rosenberg.png VectorY Appoints Seasoned Biotech Leader Adam Rosenberg as Chair of the Board - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.vectorytx.com/sr-scientist-bioassay-development daily 0.75 2025-01-15 https://www.vectorytx.com/qa-specialist daily 0.75 2025-06-12 https://www.vectorytx.com/chief-of-staff daily 0.75 2025-05-26 https://www.vectorytx.com/junior-scientist-bioanalytics daily 0.75 2025-06-03 https://www.vectorytx.com/head-of-clinical-operations daily 0.75 2025-06-03 https://www.vectorytx.com/leadership daily 0.75 2026-02-05 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/6c4750b0-559b-46b9-bc57-f6f52d605b50/Jim+Scibetta.jpg Leadership https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/c39c6c26-4a5b-4568-84d2-49076799c020/Sander+van+Deventer.jpg Leadership https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/0b11c9a6-46d8-44da-908d-9a1ddd0470ba/OlgaUspenskaya.jpg Leadership https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/f6b6d372-f8c0-4214-a71c-7656f1b6c2e2/JessicaAtkinson.jpg Leadership https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/b3bb233b-4b79-4bf4-8f58-27a8132e9630/BarbaraSanders.jpg Leadership https://www.vectorytx.com/bio-jim-scibetta daily 0.75 2026-02-05 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/6c4750b0-559b-46b9-bc57-f6f52d605b50/Jim+Scibetta.jpg https://www.vectorytx.com/leadership-staging-1 daily 0.75 2025-07-14 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/6c4750b0-559b-46b9-bc57-f6f52d605b50/Jim+Scibetta.jpg Leadership (staging) carrousel https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/c39c6c26-4a5b-4568-84d2-49076799c020/Sander+van+Deventer.jpg Leadership (staging) carrousel https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/0b11c9a6-46d8-44da-908d-9a1ddd0470ba/OlgaUspenskaya.jpg Leadership (staging) carrousel https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/f6b6d372-f8c0-4214-a71c-7656f1b6c2e2/JessicaAtkinson.jpg Leadership (staging) carrousel https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/b3bb233b-4b79-4bf4-8f58-27a8132e9630/BarbaraSanders.jpg Leadership (staging) carrousel https://www.vectorytx.com/bio-sander-van-deventer daily 0.75 2025-07-22 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/c39c6c26-4a5b-4568-84d2-49076799c020/Sander+van+Deventer.jpg https://www.vectorytx.com/bio-olga-uspenskayacadoz daily 0.75 2025-07-22 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/0b11c9a6-46d8-44da-908d-9a1ddd0470ba/OlgaUspenskaya.jpg https://www.vectorytx.com/bio-jessica-atkinson daily 0.75 2025-07-22 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/f6b6d372-f8c0-4214-a71c-7656f1b6c2e2/JessicaAtkinson.jpg https://www.vectorytx.com/bio-barbara-sanders daily 0.75 2025-07-22 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/b3bb233b-4b79-4bf4-8f58-27a8132e9630/BarbaraSanders.jpg https://www.vectorytx.com/senior-director-of-program-management daily 0.75 2025-07-31 https://www.vectorytx.com/senior-scientist-process-development daily 0.75 2025-08-06 https://www.vectorytx.com/technician-process-development daily 0.75 2025-08-06 https://www.vectorytx.com/senior-manager-strategic-operations-office-of-the-ceo daily 0.75 2025-08-29 https://www.vectorytx.com/expanded-access-policy daily 0.75 2025-12-30 https://www.vectorytx.com/clinical-trial-administrator daily 0.75 2026-01-13 https://www.vectorytx.com/technician-discovery daily 0.75 2026-03-03 https://www.vectorytx.com/technician-analytical-development daily 0.75 2026-03-19 https://www.vectorytx.com/privacy-statement daily 0.75 2026-04-02 https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/5eb58118-e008-406b-9c00-18c807fbc5da/Screenshot+2026-03-24+at+10.04.52.png https://images.squarespace-cdn.com/content/v1/6393094bc2c21800678e46ed/92707d89-e419-448b-bee3-27946346f493/Screenshot+2026-03-24+at+10.08.06.png